AIRLINK 193.56 Decreased By ▼ -1.27 (-0.65%)
BOP 9.95 Increased By ▲ 0.14 (1.43%)
CNERGY 7.93 Increased By ▲ 0.57 (7.74%)
FCCL 40.65 Increased By ▲ 2.07 (5.37%)
FFL 16.86 Increased By ▲ 0.41 (2.49%)
FLYNG 27.75 Increased By ▲ 0.21 (0.76%)
HUBC 132.58 Increased By ▲ 0.83 (0.63%)
HUMNL 13.89 Increased By ▲ 0.03 (0.22%)
KEL 4.60 Decreased By ▼ -0.06 (-1.29%)
KOSM 6.62 Decreased By ▼ -0.04 (-0.6%)
MLCF 47.60 Increased By ▲ 2.21 (4.87%)
OGDC 213.91 Decreased By ▼ -0.08 (-0.04%)
PACE 6.93 Increased By ▲ 0.07 (1.02%)
PAEL 41.24 Increased By ▲ 1.18 (2.95%)
PIAHCLA 17.15 Increased By ▲ 0.36 (2.14%)
PIBTL 8.41 Increased By ▲ 0.09 (1.08%)
POWER 9.64 Increased By ▲ 0.21 (2.23%)
PPL 182.35 Increased By ▲ 0.16 (0.09%)
PRL 41.96 Increased By ▲ 0.13 (0.31%)
PTC 24.90 Increased By ▲ 0.34 (1.38%)
SEARL 106.84 Increased By ▲ 4.31 (4.2%)
SILK 0.99 Decreased By ▼ -0.01 (-1%)
SSGC 40.10 Increased By ▲ 0.66 (1.67%)
SYM 17.47 Increased By ▲ 0.14 (0.81%)
TELE 8.84 Increased By ▲ 0.08 (0.91%)
TPLP 12.75 No Change ▼ 0.00 (0%)
TRG 66.95 Increased By ▲ 1.55 (2.37%)
WAVESAPP 11.33 Increased By ▲ 0.22 (1.98%)
WTL 1.79 Increased By ▲ 0.09 (5.29%)
YOUW 4.07 Increased By ▲ 0.13 (3.3%)
BR100 12,045 Increased By 70.8 (0.59%)
BR30 36,580 Increased By 433.6 (1.2%)
KSE100 114,038 Increased By 594.4 (0.52%)
KSE30 35,794 Increased By 159 (0.45%)

With the reference to SRO 412/2014 by Drug Regulatory Authority; Aamir Iqbal, Senior Vice Chairman of the Federation of Pakistan Chamber of Commerce and Industry Committee on Health Care, humility appealed Prime Minister of Pakistan, Mian Mohammad Nawaz Sharif, Finance Minister Ishaq Dar, Minister National Health Services and application of regulatory and communicated to Ms Tarar Saira Afzal to intervene directly in the case about the ban on the sale of Skin care products, herbal, traditional, Chinese, and various food supplements, imported medicines.
He raised the issue that due to such steps may result in the ill-treatment of users and millions of patients may affect the trafficking, parallel trade import and ESP, spurious and fake products will be encouraged. According to international practice and international custom tariffs and import policy under the category of cosmetic products already have been classified.
Human resources and manpower, and the ability of pharmaceutical registration DRA Pharma importers paid a license fee, and they still have the board's agenda, nor do they consider Registration date for the ESP biological and Research Thousands of products, are pending applications are pending in drap. -PR

Copyright Business Recorder, 2015

Comments

Comments are closed.